Circular RNAs in Prostate Cancer: Is it Time to Further Explore Liquid Biopsies?

Author:

Yu Jianpeng1,Li Hanlin1,Shang Zhiqun1,Niu Yuanjie1

Affiliation:

1. Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China

Abstract

Background: Although diagnosis and treatment of prostate cancer (PCa) have evolved rapidly in recent years, clinically significant molecular biomarkers are still needed to lower the mortality. Circular RNAs (circRNAs) are a poorly characterized component of PCa transcriptome. Recently, since the development of deep RNA sequencing and novel bioinformatic pipelines, emerging evidence suggests circRNAs to have diverse functions in the development and progression of PCa. Thus, we attempt to summarize the current situation and potential development prospects about the role of circRNAs in PCa liquid biopsies. Methods: The role of circRNAs in PCa was summarized by searching the literature related to circRNAs in PubMed in recent years. Results: Deregulation of circRNAs is associated with cell proliferation, apoptosis, cell invasion, migration, as well as metastasis in PCa. Because of the high stability and tissue specificity of circRNAs, with improved detection methodologies, circRNAs may be predictive biomarkers in liquid biopsies. Conclusion: From the perspective of recent research, with the development of high-throughput sequencing and novel bioinformatics tools, knowledge of circRNAs will be further expanded. Improved technologies will make personalized precision medicine less of a paper exercise. It is time to further explore circRNA in liquid biopsies.

Funder

Natural Science Foundation of Tianjin

Second Hospital of Tianjin Medical University

Scientific Research Project of Tianjin Education Commission

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology,General Medicine

Reference61 articles.

1. Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2019. CA Cancer J Clin 2019,69(1),7-34

2. de Bono J.S.; Logothetis C.J.; Molina A.; Fizazi K.; North S.; Chu L.; Chi K.N.; Jones R.J.; Goodman O.B.; Saad F.; Staffurth J.N.; Mainwaring P.; Harland S.; Flaig T.W.; Hutson T.E.; Cheng T.; Patterson H.; Hainsworth J.D.; Ryan C.J.; Sternberg C.N.; Ellard S.L.; Fléchon A.; Saleh M.; Scholz M.; Efstathiou E.; Zivi A.; Bianchini D.; Loriot Y.; Chieffo N.; Kheoh T.; Haqq C.M.; Scher H.I.; Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011,364(21),1995-2005

3. Ryan C.J.; Smith M.R.; de Bono J.S.; Molina A.; Logothetis C.J.; de Souza P.; Fizazi K.; Mainwaring P.; Piulats J.M.; Ng S.; Carles J.; Mulders P.F.A.; Basch E.; Small E.J.; Saad F.; Schrijvers D.; Van Poppel H.; Mukherjee S.D.; Suttmann H.; Gerritsen W.R.; Flaig T.W.; George D.J.; Yu E.Y.; Efstathiou E.; Pantuck A.; Winquist E.; Higano C.S.; Taplin M.E.; Park Y.; Kheoh T.; Griffin T.; Scher H.I.; Rathkopf D.E.; Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 2013,368(2),138-148

4. Scher H.I.; Fizazi K.; Saad F.; Taplin M.E.; Sternberg C.N.; Miller K.; de Wit R.; Mulders P.; Chi K.N.; Shore N.D.; Armstrong A.J.; Flaig T.W.; Fléchon A.; Mainwaring P.; Fleming M.; Hainsworth J.D.; Hirmand M.; Selby B.; Seely L.; de Bono J.S.; Investigators A.; Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 2012,367(13),1187-1197

5. Scher H.I.; Beer T.M.; Higano C.S.; Anand A.; Taplin M.E.; Efstathiou E.; Rathkopf D.; Shelkey J.; Yu E.Y.; Alumkal J.; Hung D.; Hirmand M.; Seely L.; Morris M.J.; Danila D.C.; Humm J.; Larson S.; Fleisher M.; Sawyers C.L.; Prostate cancer foundation/department of defense prostate cancer clinical trials consortium. Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1–2 study. Lancet 2010,375(9724),1437-1446

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3